Multiple roles of toll-like receptor 4 in colorectal cancer
- PMID: 25076949
- PMCID: PMC4097957
- DOI: 10.3389/fimmu.2014.00334
Multiple roles of toll-like receptor 4 in colorectal cancer
Abstract
Toll-like receptor (TLR) signaling has been implicated in the inflammatory responses in intestinal epithelial cells (IECs). Such inflammatory signals mediate complex interactions between commensal bacteria and TLRs and are required for IEC proliferation, immune response, repair, and homeostasis. The upregulation of certain TLRs in colorectal cancer (CRC) tissues suggests that TLRs may play an essential role in the prognosis of chronic and inflammatory diseases that ultimately culminate in CRC. Here, we provide a comprehensive review of the literature on the involvement of the TLR pathway in the initiation, progression, and metastasis of CRC, as well as inherited genetic variation and epigenetic regulation. The differential expression of TLRs in epithelial cells has also been discussed. In particular, we emphasize the physiological role of TLR4 in CRC development and pathogenesis, and propose novel and promising approaches for CRC therapeutics with the aid of TLR ligands.
Keywords: colorectal cancer; immune response; inflammation; ligand; toll-like receptor 4.
Figures
Similar articles
-
Emerging role of Toll-like receptor 4 in hepatocellular carcinoma.J Hepatocell Carcinoma. 2015 Feb 16;2:11-7. doi: 10.2147/JHC.S44515. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508190 Free PMC article. Review.
-
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.World J Gastroenterol. 2014 Dec 21;20(47):17699-708. doi: 10.3748/wjg.v20.i47.17699. World J Gastroenterol. 2014. PMID: 25548469 Free PMC article. Review.
-
The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis.Semin Immunopathol. 2008 Feb;30(1):3-9. doi: 10.1007/s00281-007-0099-7. Epub 2007 Nov 20. Semin Immunopathol. 2008. PMID: 18026955 Review.
-
Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammation.J Immunol. 2014 Dec 15;193(12):6103-13. doi: 10.4049/jimmunol.1303083. Epub 2014 Nov 5. J Immunol. 2014. PMID: 25378591
-
Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease.Avicenna J Med Biotechnol. 2022 Jul-Sep;14(3):188-195. doi: 10.18502/ajmb.v14i3.9825. Avicenna J Med Biotechnol. 2022. PMID: 36061133 Free PMC article.
Cited by
-
Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer.Oncotarget. 2016 Jun 28;7(26):40106-40114. doi: 10.18632/oncotarget.9496. Oncotarget. 2016. PMID: 27223258 Free PMC article.
-
TLR4 Expression in Ex-Lichenoid Lesions-Oral Squamous Cell Carcinomas and Its Surrounding Epithelium: The Role of Tumor Inflammatory Microenvironment.Biomolecules. 2022 Feb 28;12(3):385. doi: 10.3390/biom12030385. Biomolecules. 2022. PMID: 35327577 Free PMC article.
-
Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).Mol Med Rep. 2022 Jul;26(1):244. doi: 10.3892/mmr.2022.12760. Epub 2022 Jun 3. Mol Med Rep. 2022. PMID: 35656886 Free PMC article. Review.
-
Methamphetamine alters the TLR4 signaling pathway, NF-κB activation, and pro-inflammatory cytokine production in LPS-challenged NR-9460 microglia-like cells.Mol Immunol. 2020 May;121:159-166. doi: 10.1016/j.molimm.2020.03.013. Epub 2020 Mar 26. Mol Immunol. 2020. PMID: 32222586 Free PMC article.
-
Investigating the TLR9 mRNA Expression Level in Different Histological Types of Colorectal Polyps.Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2299-2302. doi: 10.31557/APJCP.2019.20.8.2299. Asian Pac J Cancer Prev. 2019. PMID: 31450898 Free PMC article.
References
-
- Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol (2000) 164(2):554–710.4049/jimmunol.164.2.554 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
